C De Nunzio1, G Franco2, L Cindolo3, R Autorino4, A Cicione5, S Perdonà6, M Falsaperla7, M Gacci8, C Leonardo2, R Damiano5, M De Sio4, A Tubaro9. 1. University "La Sapienza", Ospedale Sant'Andrea, Dept. of Urology, Roma, Italy. Electronic address: cosimodenunzio@virgilio.it. 2. University "La Sapienza", Policlinico Umberto I°, Dept. of Urology, Roma, Italy. 3. Ospedale Padre Pio Da Pietrelcina, Dept. of Urology, Vasto, Italy. 4. Clinica Urologica, 2nd University of Naples, Italy. 5. Urology Unit, Magna Grecia University of Catanzaro, Italy. 6. Istituto Nazionale Tumori, Fondazione G Pascale, Dept. of Urology, Napoli, Italy. 7. AOU Policlinico Vittorio Emanuele, Dept. of Urology, Catania, Italy. 8. Careggi Hospital, University of Florence, Dept. of Urology, Firenze, Italy. 9. University "La Sapienza", Ospedale Sant'Andrea, Dept. of Urology, Roma, Italy.
Abstract
INTRODUCTION: To evaluate the applicability of a modified Clavien classification system (CCS) in grading postoperative complications of transurethral resection of bladder tumours (TURB). MATERIALS AND METHODS: A series of patients undergoing monopolar TURB from April 2011 to March 2012 at five Italian centers were enrolled. All complications occurring within the first 30-day postoperative period were prospectively recorded and graded according to the CCS. RESULTS: Overall, 275 patients were included. Median age was 71 (63/78) years; median BMI was 28 (25.4/30.8) Kg/m(2), median tumour size was 2 (1-3) cm; median number of tumour lesions was 1 (1-3). Median operative time was 30 (20/45) min. Fifty-seven complications were recorded in 43 patients. Overall postoperative morbidity rate was 16%. Most of the complications were not serious and classified as Clavien type I (42 cases; 74%) or II (8 cases, 14%). Higher grade complications were scarce: CCS IIIa in 1 case (2%) and CCS IIIb in six cases (10%). No TURB related death was reported. Six patients were re-operated due to significant bleeding or clot retention on postoperative days 2-7. On univariate (73.5 ± 38 versus 36.7 ± 21.6 min) and multivariate analysis longer operative time was an independent predictor of complications (OR: 1.06 per min, 95%CI 1.04-1.08, p = 0.001). CONCLUSIONS: A modified CCS can be used as a standardized tool to objectively define the complications of TURB which confirms to be a safe procedure with a low surgical morbidity. This tool can be used to aid in patient counselling and to facilitate scientific assessment.
INTRODUCTION: To evaluate the applicability of a modified Clavien classification system (CCS) in grading postoperative complications of transurethral resection of bladder tumours (TURB). MATERIALS AND METHODS: A series of patients undergoing monopolar TURB from April 2011 to March 2012 at five Italian centers were enrolled. All complications occurring within the first 30-day postoperative period were prospectively recorded and graded according to the CCS. RESULTS: Overall, 275 patients were included. Median age was 71 (63/78) years; median BMI was 28 (25.4/30.8) Kg/m(2), median tumour size was 2 (1-3) cm; median number of tumour lesions was 1 (1-3). Median operative time was 30 (20/45) min. Fifty-seven complications were recorded in 43 patients. Overall postoperative morbidity rate was 16%. Most of the complications were not serious and classified as Clavien type I (42 cases; 74%) or II (8 cases, 14%). Higher grade complications were scarce: CCS IIIa in 1 case (2%) and CCS IIIb in six cases (10%). No TURB related death was reported. Six patients were re-operated due to significant bleeding or clot retention on postoperative days 2-7. On univariate (73.5 ± 38 versus 36.7 ± 21.6 min) and multivariate analysis longer operative time was an independent predictor of complications (OR: 1.06 per min, 95%CI 1.04-1.08, p = 0.001). CONCLUSIONS: A modified CCS can be used as a standardized tool to objectively define the complications of TURB which confirms to be a safe procedure with a low surgical morbidity. This tool can be used to aid in patient counselling and to facilitate scientific assessment.
Authors: Mario W Kramer; Jens J Rassweiler; Jan Klein; Alexey Martov; Nikolay Baykov; Lukas Lusuardi; Günter Janetschek; Rodolfo Hurle; Mathias Wolters; Mahmoud Abbas; Christoph A von Klot; Armin Leitenberger; Markus Riedl; Udo Nagele; Axel S Merseburger; Markus A Kuczyk; Marko Babjuk; Thomas R W Herrmann Journal: World J Urol Date: 2015-04-25 Impact factor: 4.226
Authors: Mario W Kramer; Mathias Wolters; Hannes Cash; Stephan Jutzi; Florian Imkamp; Markus A Kuczyk; Axel S Merseburger; Thomas R W Herrmann Journal: World J Urol Date: 2014-06-17 Impact factor: 4.226
Authors: Sławomir Poletajew; Tomasz Ilczuk; Wojciech Krajewski; Grzegorz Niemczyk; Agata Cyran; Łukasz Białek; Piotr Radziszewski; Barbara Górnicka; Piotr Kryst Journal: World J Surg Oncol Date: 2020-08-19 Impact factor: 2.754
Authors: Sławomir Poletajew; Wojciech Krajewski; Dominika Gajewska; Joanna Sondka-Migdalska; Michał Borowik; Paweł Buraczyński; Mateusz Dzięgała; Marcin Łykowski; Maciej Przudzik; Andrzej Tukiendorf; Rafał Woźniak; Krzysztof Bar; Zbigniew Jabłonowski; Marek Roslan; Marcin Słojewski; Romuald Zdrojowy; Piotr Radziszewski; Konrad Dziobek Journal: Arch Med Sci Date: 2019-10-07 Impact factor: 3.318